Stoke Therapeutics (STOK) PT Raised to $36 at Canaccord Genuity

January 5, 2026 4:24 AM EST Send to a Friend
Canaccord Genuity analyst Sumant Kulkami ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login